NCT06951646 2026-03-09ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)Second Xiangya Hospital of Central South UniversityPhase 2 Recruiting70 enrolled